Jim Frakes
Chief Executive Officer and Chief Financial Officer
Replay available
Aethlon Medical, Inc. (NASDAQ: AEMD) Q4 2025 earnings conference call, held 2025-06-26. Replay captured from the company's public earnings webcast.

Chief Executive Officer and Chief Financial Officer
Analyst at Zacks Investment Research
Analyst at H.C. Wainwright & Co.
Analyst at Maxim Group
Good afternoon and welcome to the Athlon Medical fourth quarter fiscal 2025 earnings and corporate update conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press far then one on your telephone keypad. To withdraw your question, please press star, then two. Please note, this event is being recorded. I would now like to turn the conference over to Jim Frakes, Chief Executive Officer and Chief Financial Officer. Please go ahead. Thank you, Operator, and good afternoon, everyone. Welcome to Athlon Medical's Fiscal Fourth Quarter 2025 Earnings Conference Call. My name is Jim Frakes, and I am the Chief Executive Officer for and Chief Financial Officer of Athlon Medical. Now, I have some bad news and some good news to report on this call. The bad news is since Dr. Stephen LaRosa, our Chief Medical Officer, is out on a family vacation, you'll have to listen to my soliloquy throughout this call. But the good news is that we made more progress advancing in the clinic with our products this period than in any quarter since I've been with Athlon. At 4.15 p.m. Eastern Time today, Athlon Medical released financial results for its fiscal fourth quarter ended March 31, 2025. If you have not seen or received Athlon Medical's earnings release, please visit the investors page at www.athlonmedical.com to view it. Following this introduction and the reading of the company's forward-looking statement disclaimers, I will provide an overview of our strategy and recent developments. I will then make some brief remarks on Athlon's financials. We will then open up the call ...